Optimal Use of Ganciclovir and Valganciclovir in Transplanted Patients: How Does It Relate to the Outcome?
Table 1
Patients’ demographic and clinical characteristics (N = 148).
Characteristics (unit)
Value
Age (years)
37.8 ± 15.5
Sex (M/F)
90 (60.8%) / 58 (39.2%)
Actual body weight (kg)
62.3 ± 24.6
Height (cm)
163.4 ± 17.6
Ideal body weight (kg)
58.1 ± 11.9
Overweight (ABW > 120% of IBW)
36 (24.3%)
Donor (alive/cadaveric)
106 (71.6%) / 42 (28.4%)
First/Second transplantation
128 (86.5%) / 20 (13.5%)
CMV serostatus (CMV IgG antibody)
Moderate risk (D+/R+)
148 (100%)
Data presented as mean ± SD or number (%) of the patients. CMV: cytomegalovirus; IgG: immunoglobulin G; SD: standard deviation; M: male; F: female; ABW: actual body weight; IBW: ideal body weight; D/R: donor/recipient.
